Vimab Group Ab Stock Current Valuation
| VIMAB Stock | 7.90 0.05 0.63% |
Valuation analysis of VIMAB Group AB helps investors to measure VIMAB Group's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that VIMAB Group's price fluctuation is very risky at this time. Calculation of the real value of VIMAB Group AB is based on 3 months time horizon. Increasing VIMAB Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the VIMAB stock is determined by what a typical buyer is willing to pay for full or partial control of VIMAB Group AB. Since VIMAB Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of VIMAB Stock. However, VIMAB Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.9 | Real 7.58 | Hype 7.9 |
The intrinsic value of VIMAB Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence VIMAB Group's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of VIMAB Group AB helps investors to forecast how VIMAB stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of VIMAB Group more accurately as focusing exclusively on VIMAB Group's fundamentals will not take into account other important factors: VIMAB Group AB Company Current Valuation Analysis
VIMAB Group's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current VIMAB Group Current Valuation | 202.7 M |
Most of VIMAB Group's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VIMAB Group AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, VIMAB Group AB has a Current Valuation of 202.7 M. This is 97.22% lower than that of the Industrials sector and significantly higher than that of the Consulting Services industry. The current valuation for all Sweden stocks is 98.78% higher than that of the company.
VIMAB Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VIMAB Group's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VIMAB Group could also be used in its relative valuation, which is a method of valuing VIMAB Group by comparing valuation metrics of similar companies.VIMAB Group is currently under evaluation in current valuation category among its peers.
VIMAB Fundamentals
| Return On Equity | 2.92 | |||
| Return On Asset | -0.0135 | |||
| Current Valuation | 202.7 M | |||
| Shares Outstanding | 19.4 M | |||
| Shares Owned By Insiders | 7.69 % | |||
| Price To Book | 2.44 X | |||
| Price To Sales | 0.96 X | |||
| Revenue | 70.34 M | |||
| Gross Profit | 115.7 M | |||
| EBITDA | (2.11 M) | |||
| Book Value Per Share | 4.81 X | |||
| Earnings Per Share | 50.93 X | |||
| Number Of Employees | 10 | |||
| Beta | 1.74 | |||
| Market Capitalization | 195.96 M | |||
| Annual Yield | 3.71 % |
About VIMAB Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VIMAB Group AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VIMAB Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VIMAB Group AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VIMAB Stock Analysis
When running VIMAB Group's price analysis, check to measure VIMAB Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VIMAB Group is operating at the current time. Most of VIMAB Group's value examination focuses on studying past and present price action to predict the probability of VIMAB Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VIMAB Group's price. Additionally, you may evaluate how the addition of VIMAB Group to your portfolios can decrease your overall portfolio volatility.